Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Radiprodil by Neurvati Neurosciences for Tuberous Sclerosis: Likelihood of Approval
Radiprodil is under clinical development by Neurvati Neurosciences and currently in Phase II for Tuberous Sclerosis. According to GlobalData, Phase...
Data Insights
Radiprodil by Neurvati Neurosciences for Seizures: Likelihood of Approval
Radiprodil is under clinical development by Neurvati Neurosciences and currently in Phase II for Seizures. According to GlobalData, Phase II...